Centro Médico Dra. De Salvo

Buenos Aires CP1426ABO

0 studies enrolling now · 9 studies all time

What they study most

Asthma, Bronchiectasis, Chronic Obstructive Pulmonary Disease, Chronic Thromboembolic Pulmonary Hypertension, Epidermolysis Bullosa, Heart Failure With Preserved Ejection Fraction, Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement

Studies at this site

• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
• A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Completed
• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease — Stopped early
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment — Stopped early
• Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa — Completed
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis — Completed